相关实验视频
Updated: Jul 2, 2025

00:13
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
Published on: September 28, 2019
7.4K
在胰腺突切除术后术后并发症的术后德克萨美沙的影响:一个多中心随机对照试验
Haoda Chen1, Ying Wang2, Kuirong Jiang3
1Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Annals of surgery
|February 22, 2024
概括
术后使用德克萨米他并没有显著减少胰腺除术后的整体术后并发症. 然而,它在主要胰腺管直径为3毫米或更小的患者中显示出显著的益处.
科学领域:
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
- 麻醉学 麻醉学
背景情况:
- 众所周知,强效的葡萄糖皮质激素德克萨米他可以改善一般外科手术的术后结果.
- 它对减少胰腺切除术后并发症的具体影响仍然不确定.
研究的目的:
- 为了研究术前甲松在减轻胰腺除术后术后并发症的疗效.
- 评估对综合并发症指数 (CCI) 和胰腺抽等特定并发症的影响.
主要方法:
- 一个多中心,双盲,随机对照试验,涉及265名接受选择性胰腺二切除术的患者.
- 参与者在麻醉诱导后接受了德克萨米他 (0.2毫克/千克) 或静脉注射的盐水安慰剂.
- 主要终点是30天的综合并发症指数 (CCI) 得分.
主要成果:
- 德克萨米他和安慰剂组之间的CCI平均得分没有显著差异 (14.0对17.9).
- 主要并发症 (Clavien-Dindo等级≥III) 和术后胰腺的发生率在各组之间也相似.
- 在接受德克萨米他 (平均差异: -6.4) 的主胰腺管≤3毫米的患者中观察到CCI得分显著降低.
结论:
- 在胰腺除术后的30天内,术后的整体术后并发症没有显著降低.
- 德克萨米他可能为患有较小的主胰腺通道的特定亚组患者提供潜在的益处.
相关概念视频
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
84
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
84
Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
Endoscopic Procedures V: ERCP
228
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
228
Depolarizing Blockers: Pharmocokinetics
326
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
326
Acute Pancreatitis II: Clinical Manifestations and Management
124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124
Parenteral Anesthetics: Overview
125
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
125

